Status:

COMPLETED

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Lead Sponsor:

Palvella Therapeutics, Inc.

Conditions:

BCCs in Gorlin Syndrome Patients

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

A Phase 2b study looks at the safety and efficacy of a treatment that is being investigated for people with certain diseases. This study will be conducted at multiple centers in the United States wher...

Eligibility Criteria

Inclusion

  • Key
  • Adults, 18 years or older
  • Meet diagnostic criteria for Gorlin Syndrome
  • Willing to avoid application of a non-study topical medication to the face (prescription or over the counter) during the study.
  • Willing to forego treatment of BCCs with anything other than the study medication except when the Investigator believes that delay of treatment of a BCC potentially might compromise the health of the subject. During the trial, the only allowed form of BCC treatment is surgical.
  • Participant will be encouraged to use their preferred sunscreen with a sun protector factor (SPF) of at least 30 daily
  • Key

Exclusion

  • Recently participated in a clinical trial evaluating an investigational product for the treatment of BCCs or Gorlin Syndrome within 3 months prior to to starting study medication. Participant can start the study screening period prior to completing the 3 month washout.
  • Recently used topical or systemic (oral) treatment that might interfere with the evaluation of the study medication.

Key Trial Info

Start Date :

May 6 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 13 2023

Estimated Enrollment :

73 Patients enrolled

Trial Details

Trial ID

NCT04893486

Start Date

May 6 2021

End Date

March 13 2023

Last Update

August 29 2024

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

Mayo Clinic

Scottsdale, Arizona, United States, 85259

2

Burke Pharmaceuticals Research

Hot Springs, Arkansas, United States, 71913

3

Stanford Univeristy

Palo Alto, California, United States, 94304

4

Park Avenue Dermatology

Orange Park, Florida, United States, 32073